Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: No clinical relevance in patients with breast cancer;Intensieve bewerking van schildwachtklieren om micrometastasen te detecteren: Geen klinische relevantie bij patiënten met mammacarcinoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 49, 2004, Pages 2428-2432

  Meijnen, Ph ^a   Peterse, J L ^a   Nieweg, O E ^a   Rutgers, E J Th ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 10244263531     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on adjuvant therapy of primary breast cancer. J Clin Oncol 2001;19:3817-27.
2. Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, et al. Clinicopathologic features of metastasis in non-sentinel lymph nodes of breast carcinoma patients. Cancer 2003;98:2307-15.
3. Tjan-Heijnen VC, Bult P, Widt-Evert LM de, Ruers TJM, Beex LV. Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 2001;70:81-8.
4. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, et al. European Working Group for Breast Screening Pathology. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003;39:1654-67.
5. Veen H van der, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-70.
6. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider jr HC. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study. Cancer 1999;86:990-6.
7. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53.
8. Rutgers EJ. Sentinel node procedure in breast carcinoma: a valid tool to omit unnecessary axillary treatment or even more? Eur J Cancer 2004;40:182-6.
9. Roumen RMH, Pijpers HJ, Thunnissen FBJM, Ruers TJM. Samenvatting van de richtlijn 'Schildwachtklierbiopsie bij mammacarcinoom'. Ned Tijdschr Geneeskd 2000;144:1864-7.
10. Rutgers EJTh, Nortier JWR, Tuut MK, Tienhoven G van, Struikmans H, Bontenbal M, et al. CBO-richtlijn 'Behandeling van het mammacarcinoom'. Ned Tijdschr Geneeskd 2002;146:2144-51.
11. Bourez RL, Rutgers EJ, Velde CJ van de. Will we need lymph node dissection at all in the future? Clin Breast Cancer 2002;3:315-22.
12. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77:165-70.
13. Roumen RM, Kuijt GP, Liem IH, Beek MW van. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001;88:1639-43.
14. Hansen NM, Grube BJ, Giuliano AE. The time has come to change the algorithm for the surgical management of early breast cancer. Arch Surg 2002;137:1131-5.
15. Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310-4.
16. Krag D. Why perform randomized clinical trials for sentinel node surgery for breast cancer? Am J Surg 2001;182:411-3.
17. Grube BJ, Giuliano AE, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001;20:230-7.
18. Bourez RL, Rutgers EJ. The European Organization for Research and Treatment of Cancer (EORTC) Breast Cancer Group: quality control of surgical trials. Surg Oncol Clin N Am 2001;10:807-19, ix.
19. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer, J Clin Oncol 1997;15:2345-50.
20. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-41.
21. Reynolds C, Mick R, Donohue JH, Grant CS, Parley DR, Callans LS, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-6.
22. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reinigen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20.
23. Wijsman JH, Broekhuizen LN, Peterse JL, Rutgers EJ. Micro-metastases in sentinel lymph nodes of patients with ductal carcinoma in situ of the breast have no clinical relevance. Breast Cancer Res Treat [ter perse].
24. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-84.
25. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, Diest PJ van. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-2.
26. Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 1998;69:212-8.
27. Nationaal Borstkanker Overleg Nederland (NABON). Richtlijn: behandeling van het mammacarcinoom. Alphen aan den Rijn: Van Zuiden Communications; 2002.
28. Sobin LH, Wittekind Ch. TNM: classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
29. Wittekind Ch, Greene FL, Hutter RVP, Sobin LH, Henson DE, editors. TNM supplement: a commentary on uniform use. 3rd ed, New York: Wiley-Liss; 2003.
30. Huvos AG, Hutter RVP, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-6.
31. Schwartz GF, Giuliano AE, Veronesi U. Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542-51.
32. Giard RWM, Coebergh JWW. Steeds geavanceerder detectie van lymfkliermetastasen: de problemen van stadiummigratie. Ned Tijdschr Geneeskd 1999;143:1766-71.
33. Loo EM van der, Hop WCJ, Tervoort MA, Graaf PW de. Zeer geringe kans op andere kliermetastasen in de oksel bij borstkankerpatiënten met een kleine schildwachtkliermetastase zonder extranodale tumorgroei. Ned Tijdschr Geneeskd 2004;148:938-43.